{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:15Z","timestamp":1786980075690,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00392-021-01932-w","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T15:28:50Z","timestamp":1630682930000},"page":"1983-1992","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of implantation depth on outcomes of new-generation balloon-expandable transcatheter heart valves"],"prefix":"10.1007","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0799-7478","authenticated-orcid":false,"given":"Won-Keun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Renker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Doerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Nef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong-Hoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian W.","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,2]]},"reference":[{"issue":"38","key":"1932_CR1","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1093\/eurheartj\/ehz275","volume":"40","author":"GCM Siontis","year":"2019","unstructured":"Siontis GCM, Overtchouk P, Cahill TJ et al (2019) Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J 40(38):3143\u20133153. https:\/\/doi.org\/10.1093\/eurheartj\/ehz275","journal-title":"Eur Heart J"},{"issue":"10","key":"1932_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.4244\/EIJ-D-19-00788","volume":"15","author":"M Barbanti","year":"2019","unstructured":"Barbanti M, Webb JG, Dvir D et al (2019) Residual challenges in TAVI: moving forward. EuroIntervention 15(10):857\u2013866. https:\/\/doi.org\/10.4244\/EIJ-D-19-00788","journal-title":"EuroIntervention"},{"issue":"5","key":"1932_CR3","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1093\/ejcts\/ezs533","volume":"42","author":"AP Kappetein","year":"2012","unstructured":"Kappetein AP, Head SJ, Genereux P et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42(5):S45-60. https:\/\/doi.org\/10.1093\/ejcts\/ezs533","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"1932_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jcin.2015.02.005","volume":"8","author":"AS Petronio","year":"2015","unstructured":"Petronio AS, Sinning JM, Van Mieghem N et al (2015) Optimal implantation depth and adherence to guidelines on permanent pacing to improve the results of transcatheter aortic valve replacement with the medtronic core valve system: the core valve prospective, international, post-market ADVANCE-II study JACC. Cardiovasc Interv 8(6):837\u2013846. https:\/\/doi.org\/10.1016\/j.jcin.2015.02.005","journal-title":"Cardiovasc Interv"},{"issue":"3","key":"1932_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12330","volume":"36","author":"M Vavuranakis","year":"2018","unstructured":"Vavuranakis M, Kariori M, Scott L et al (2018) Impact of \u201chigh\u201d implantation on functionality of self-expandable bioprosthesis during the short- and long-term outcome of patients who undergo transcatheter aortic valve implantation: Is high implantation beneficial? Cardiovasc Ther 36(3):e12330. https:\/\/doi.org\/10.1111\/1755-5922.12330","journal-title":"Cardiovasc Ther"},{"issue":"6","key":"1932_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jcin.2019.07.048","volume":"13","author":"K Piayda","year":"2020","unstructured":"Piayda K, Hellhammer K, Veulemans V et al (2020) Navigating the \u201coptimal implantation depth\u201d with a self-expandable TAVR device in daily clinical practice. JACC Cardiovasc Interv 13(6):679\u2013688. https:\/\/doi.org\/10.1016\/j.jcin.2019.07.048","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"1932_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jcin.2015.09.036","volume":"9","author":"O Husser","year":"2016","unstructured":"Husser O, Pellegrini C, Kessler T et al (2016) Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 9(3):244\u2013254. https:\/\/doi.org\/10.1016\/j.jcin.2015.09.036","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"1932_CR8","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.jcin.2016.08.034","volume":"9","author":"V Mauri","year":"2016","unstructured":"Mauri V, Reimann A, Stern D et al (2016) Predictors of permanent pacemaker implantation after transcatheter aortic valve replacement with the SAPIEN 3. JACC Cardiovasc Interv 9(21):2200\u20132209. https:\/\/doi.org\/10.1016\/j.jcin.2016.08.034","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"1932_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.120.009407","volume":"14","author":"Y Sammour","year":"2021","unstructured":"Sammour Y, Banerjee K, Kumar A et al (2021) Systematic approach to high implantation of SAPIEN-3 valve achieves a lower rate of conduction abnormalities including pacemaker implantation. Circ Cardiovasc Interv 14(1):e009407. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.120.009407","journal-title":"Circ Cardiovasc Interv"},{"issue":"19","key":"1932_CR10","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","volume":"33","author":"Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S","year":"2012","unstructured":"Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33(19):2451\u20132496. https:\/\/doi.org\/10.1093\/eurheartj\/ehs109","journal-title":"Eur Heart J"},{"issue":"36","key":"1932_CR11","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Falk V, Bax JJ et al (2017) 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38(36):2739\u20132791. https:\/\/doi.org\/10.1093\/eurheartj\/ehx391","journal-title":"Eur Heart J"},{"issue":"1","key":"1932_CR12","doi-asserted-by":"publisher","first-page":"E38","DOI":"10.1002\/ccd.26464","volume":"89","author":"WK Kim","year":"2017","unstructured":"Kim WK, Praz F, Blumenstein J et al (2017) Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation. Catheter Cardiovasc Interv 89(1):E38\u2013E43. https:\/\/doi.org\/10.1002\/ccd.26464","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"1932_CR13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/pace.14155","volume":"44","author":"WK Kim","year":"2021","unstructured":"Kim WK, Mollmann H, Walther T et al (2021) Predictors of permanent pacemaker implantation after ACURATE neo transcatheter heart valve implantation. Pacing Clin Electrophysiol 44(2):410\u2013415. https:\/\/doi.org\/10.1111\/pace.14155","journal-title":"Pacing Clin Electrophysiol"},{"issue":"8","key":"1932_CR14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jcin.2015.12.023","volume":"9","author":"F De Torres-Alba","year":"2016","unstructured":"De Torres-Alba F, Kaleschke G, Diller GP et al (2016) Changes in the pacemaker rate after transition from Edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: the critical role of valve implantation height. JACC Cardiovasc Interv 9(8):805\u2013813. https:\/\/doi.org\/10.1016\/j.jcin.2015.12.023","journal-title":"JACC Cardiovasc Interv"},{"key":"1932_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.amjcard.2020.05.044","volume":"131","author":"WK Kim","year":"2020","unstructured":"Kim WK, Mollmann H, Liebetrau C et al (2020) Effectiveness and safety of the ACURATE neo prosthesis in 1,000 patients with aortic stenosis. Am J Cardiol 131:12\u201316. https:\/\/doi.org\/10.1016\/j.amjcard.2020.05.044","journal-title":"Am J Cardiol"},{"key":"1932_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa799","author":"P Genereux","year":"2021","unstructured":"C Varc-3 Writing, Genereux P, Piazza N et al (2021) Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa799","journal-title":"Eur Heart J"},{"issue":"6","key":"1932_CR17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jcin.2020.01.202","volume":"13","author":"T Rogers","year":"2020","unstructured":"Rogers T, Greenspun BC, Weissman G et al (2020) Feasibility of coronary access and aortic valve reintervention in low-risk TAVR patients. JACC Cardiovasc Interv 13(6):726\u2013735. https:\/\/doi.org\/10.1016\/j.jcin.2020.01.202","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"1932_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jcin.2017.11.004","volume":"11","author":"GHL Tang","year":"2018","unstructured":"Tang GHL, Kaneko T (2018) Assessing implant depth using aortography in transcatheter aortic valve replacement: what you see may not be what you get. JACC Cardiovasc Interv 11(2):129\u2013132. https:\/\/doi.org\/10.1016\/j.jcin.2017.11.004","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01932-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-021-01932-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01932-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T07:06:14Z","timestamp":1638428774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-021-01932-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1932"],"URL":"https:\/\/doi.org\/10.1007\/s00392-021-01932-w","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,2]]},"assertion":[{"value":"4 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"WK: proctor, advisory board or speaker honoraria from Boston Scientific, Abbott, Edwards Lifesciences, Medtronic, Meril Life Sciences, Shockwave Med. HN: proctor for Boston Scientific. CH: advisory board Medtronic. All other authors declare that they have no relevant conflict of interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committee of the Justus-Liebig University of Gie\u00dfen.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}